导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.43% | 3233/4773 |
| 近一周 | -1.78% | 2809/5465 |
| 近一月 | -2.44% | 1663/5421 |
| 近一季 | -3.41% | 1620/5231 |
| 近半年 | -4.36% | 2796/4920 |
| 近一年 | -2.41% | 3049/4394 |
| 近两年 | 36.77% | 2039/2954 |
| 近三年 | 22.45% | 1400/2253 |
| 成立以来 | 384.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.36% 3604/4961 |
7.10% 2751/5312 |
- - |
- - |
| 2025 | 16.25% 2472/4813 |
-1.56% 2694/3635 |
2.61% 1462/4076 |
16.66% 2620/4524 |
-1.35% 2908/4813 |
| 2024 | 17.63% 667/3463 |
3.61% 535/2808 |
-0.42% 762/3014 |
15.67% 1659/3129 |
-1.44% 1703/3463 |
| 2023 | -7.82% 952/2656 |
3.05% 1276/2280 |
-3.57% 834/2385 |
-0.34% 416/2515 |
-6.92% 1981/2655 |
| 2022 | -16.73% 508/2207 |
-11.15% 482/1919 |
5.45% 897/2016 |
-12.51% 715/2113 |
1.57% 1215/2208 |
| 2021 | -3.99% 936/1822 |
-2.46% 649/1255 |
1.54% 1046/1330 |
-4.19% 687/1466 |
1.18% 989/1822 |
| 2020 | 20.47% 715/1250 |
-10.59% 794/1028 |
9.43% 794/1067 |
10.68% 524/1164 |
11.25% 554/1184 |
| 2019 | 29.84% 494/1092 |
23.48% 550/754 |
1.38% 133/804 |
-1.29% 642/850 |
5.07% 754/918 |
| 2018 | -19.52% 169/834 |
- - |
- - |
- - |
-11.26% 272/691 |
| 2017 | 19.82% 191/714 |
- - |
- - |
- - |
- - |
| 2016 | -7.68% 226/605 |
- - |
- - |
- - |
- - |
| 2015 | -0.29% 258/575 |
- - |
- - |
- - |
- - |
| 2014 | 58.78% 41/237 |
- - |
- - |
- - |
- - |
| 2013 | -7.29% 121/186 |
- - |
- - |
- - |
- - |
| 2012 | 11.19% 37/140 |
- - |
- - |
- - |
- - |
| 2011 | -22.26% 49/102 |
- - |
- - |
- - |
- - |
| 2010 | -15.65% 40/58 |
- - |
- - |
- - |
- - |
| 2009 | 83.81% 15/27 |
- - |
- - |
- - |
- - |
| 2008 | -63.34% 15/26 |
- - |
- - |
- - |
- - |
| 2007 | 142.27% 10/22 |
- - |
- - |
- - |
- - |
| 2006 | 125.09% 5/14 |
- - |
- - |
- - |
- - |
| 2005 | -4.96% 10/11 |
- - |
- - |
- - |
- - |
| 2004 | -9.32% 2/4 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 万家180指数A VS. 长安沪深300非周期A(740101) |